Loading data
ECXNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 847.86 m USD | 771.53 m USD | 662.23 m USD | 515.74 m USD |
| Cost of revenue | 686.6 m USD | 611.43 m USD | 483.61 m USD | 372.13 m USD |
| Gross profit | 161.26 m USD | 160.1 m USD | 178.62 m USD | 143.61 m USD |
| Research and development expense | 123.34 m USD | 174.86 m USD | 177.68 m USD | 175.56 m USD |
| Selling, general and administrative expense | 93.84 m USD | 108.2 m USD | 131.72 m USD | — |
| Operating profit | -54.77 m USD | -122.9 m USD | -130.02 m USD | -212.59 m USD |
| Interest expense | 23.77 m USD | 18.57 m USD | 11.24 m USD | 7.41 m USD |
| Profit before tax | -67.7 m USD | -137.54 m USD | -144.42 m USD | -220.33 m USD |
| Income tax expense | 1.24 m USD | 210 k USD | -525 k USD | 3.13 m USD |
| Net income (reported basis) | -66.04 m USD | -129.77 m USD | -133.32 m USD | -223.18 m USD |
| Net income attributable to common shareholders | — | -127.73 m USD | -132.42 m USD | -274.74 m USD |
| Basic earnings per share | -0.2 USD/share | -0.39 USD/share | -0.4 USD/share | -1.15 USD/share |
| Diluted earnings per share | -0.2 USD/share | -0.39 USD/share | -0.4 USD/share | -1.15 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.